Type 2 diabetes in adults: management

Supporting evidence

• Surveillance report

• 2019 surveillance update

• 2019 surveillance of diabetes (NICE guidelines NG17, NG18, NG19 and NG28)

• Appendix A1: Summary of evidence from surveillance (NG17) (PDF 1.2 MB)

  Published:

  27 June 2019

• Appendix B1: Stakeholder consultation comments table (NG17) (PDF 1.38 MB)

  Published:

  27 June 2019

• Appendix A2: Summary of evidence from surveillance (NG28) (PDF 1.86 MB)

  Published:

  27 June 2019

• Appendix B2: Stakeholder consultation comments table (NG28) (PDF 1.86 MB)

  Published:

  27 June 2019

• Appendix A3: Summary of evidence from surveillance (NG18) (PDF 992 KB)

  Published:

  27 June 2019

• Appendix B3: Stakeholder consultation comments table (NG18) (PDF 1.26 MB)

  Published:

  27 June 2019

• Appendix A4: Summary of evidence from surveillance (NG19) (PDF 746 KB)

  Published:

  27 June 2019

• Appendix B4: Stakeholder consultation comments table (NG19) (PDF 1.04 MB)

  Published:

  27 June 2019

• Evidence review

• D: Periodontal treatment to improve diabetic control in adults with type 1 or type 2 diabetes (PDF 1.61 MB)

  Published:

  29 June 2022

• C: Continuous glucose monitoring in adults with type 2 diabetes (PDF 1.84 MB)

  Published:

  31 March 2022

• Evidence reviews

• B: Pharmacological therapies with cardiovascular and other benefits in people with type 2 diabetes (PDF 4.16 MB)

  Published:

  15 February 2022

• A: SGLT2 inhibitors for people with chronic kidney disease and type 2 diabetes (PDF 3.14 MB)

  Published:

  24 November 2021

• SGLT-2 inhibitors and GLP-1 mimetics (PDF 3.93 MB)

  Published:

  13 March 2018

• Economic analysis

• Economic model report on periodontal treatment in adults with type 1 and type 2 diabetes (PDF 555 KB)

  Published:

  29 June 2022

• Economic model report (PDF 447 KB)

  Published:

  31 March 2022

• Health economic model report (PDF 1.18 MB)

  Published:

  15 February 2022

• Full guidance

• Full guideline (PDF 5.08 MB)

  Published:

  02 December 2015

• Appendix A: Guideline development groups and declarations of interest (PDF 204 KB)

  Published:

  02 December 2015

• Appendix B: Scopes (PDF 268 KB)

  Published:

  02 December 2015

• Appendix C: Search strategies and review protocols (PDF 423 KB)

  Published:

  02 December 2015

• Appendix D: GRADE tables and meta-analysis results (PDF 1.3 MB)

  Published:

  02 December 2015

• Appendix E: Evidence tables (PDF 20.84 MB)

  Published:

  02 December 2015

• Appendix F: Full health economics report (PDF 6.06 MB)

  Published:

  02 December 2015

• Appendix G: NICE guideline CG66 deleted text (PDF 7.57 MB)

  Published:

  02 December 2015

• Appendix H: NICE guideline CG87 deleted text (PDF 955 KB)

  Published:

  02 December 2015

• Appendix I: NICE guideline CG87 deleted appendix (PDF 3.89 MB)

  Published:

  02 December 2015

• Appendix J: NMA results and input data (PDF 4.09 MB)

  Published:

  02 December 2015

• Appendix K: WinBUGS code (PDF 192 KB)

  Published:

  02 December 2015

• Appendix L: Excluded studies (PDF 1.49 MB)

  Published:

  02 December 2015